Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease

Liver International

Volumn 33, Issue 6, 2013, Pages 914-925

  Onori, Paolo ^a   Mancinelli, Romina ^a   Franchitto, Antonio ^a,b   Carpino, Guido ^c   Renzi, Anastasia ^a   Brozzetti, Stefania ^a   Venter, Julie ^d   Francis, Heather ^d   Glaser, Shannon ^d   Jefferson, Douglas M ^e   Alpini, Gianfranco ^d   Gaudio, Eugenio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Eleonora Lorillard Spencer Cenci Foundation   (Italy)

^c UNIVERSITY OF ROME FORO ITALICO   (Italy)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^e TUFTS UNIVERSITY   (United States)

Author keywords

Autosomal dominant polycystic kidney disease; Biliary epithelium; Follicle stimulating hormone; Immunohistochemistry

Indexed keywords

CYCLIC AMP; CYCLINE; FOLLITROPIN; FOLLITROPIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX;

ADULT; AGED; APOPTOSIS; ARTICLE; BILE DUCT CYST; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY POLYCYSTIC DISEASE; LIVER CYST; MALE; ONCOGENE C MYC; PROTEIN EXPRESSION;

AGED; ANIMALS; CASE-CONTROL STUDIES; CELL LINE; CELL PROLIFERATION; CHOLEDOCHAL CYST; CYCLIC AMP; CYSTS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PHOSPHORYLATION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, FSH; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84878909486     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12177     Document Type: Article

References (74)

1. Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009; 76: 149-68.
2. Drenth JP, Tahvanainen E, Te Morsche RH, et al. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease. Hepatology 2004; 39: 924-31.
3. Davila S, Furu L, Gharavi AG, et al. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 2004; 36: 575-7.
4. Russell RT, Pinson CW. Surgical management of polycystic liver disease. World J Gastroenterol 2007; 13: 5052-9.
5. Van Keimpema L, Hockerstedt K. Treatment of polycystic liver disease. Br J Surg 2009; 96: 1379-80.
6. Onori P, Franchitto A, Mancinelli R, et al. Polycystic liver diseases. Dig Liver Dis 2010; 42: 261-71.
7. Gabow PA, Johnson AM, Kaehny WD, et al. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990; 11: 1033-7.
8. Masyuk TV, Masyuk AI, Torres VE, Harris PC, Larusso NF. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3′, 5′-cyclic monophosphate. Gastroenterology 2007; 132: 1104-16.
9. Van Keimpema L, De Man RA, Drenth JP. Somatostatin analogues reduce liver volume in polycystic liver disease. Gut 2008; 57: 1338-9.
10. Drenth JP, Chrispijn M, Nagorney DM, Kamath PS, Torres VE. Medical and surgical treatment options for polycystic liver disease. Hepatology 2010; 52: 2223-30.
11. Alvaro D, Barbaro B, Franchitto A, et al. Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol 2006; 169: 877-88.
12. Alvaro D, Mancino MG, Onori P, et al. Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol 2006; 12: 3537-45.
13. Glaser SS, Onori P, Wise C, et al. Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis. Dig Liver Dis 2010; 42: 245-52.
14. Alvaro D, Onori P, Alpini G, et al. Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. Am J Pathol 2008; 172: 321-32.
15. 2+-dependent PKC isoforms. BMC Physiol 2007; 7: 6.
16. Glaser S, Demorrow S, Francis H, et al. Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms. Am J Physiol Gastrointest Liver Physiol 2008; 295: G124-36.
17. Mancinelli R, Onori P, Gaudio E, et al. Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1. Am J Physiol Gastrointest Liver Physiol 2009; 297: G11-26.
18. Richards JS, Pangas SA. The ovary: basic biology and clinical implications. J Clin Invest 2010; 120: 963-72.
19. Hunzicker-Dunn M, Maizels ET. FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal 2006; 18: 1351-9.
20. Mancinelli R, Franchitto A, Gaudio E, et al. After damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes. Am J Pathol 2010; 176: 1790-800.
21. Ryan KE, Casey SM, Canty MJ, et al. Akt and Erk signal transduction pathways are early markers of differentiation in dominant and subordinate ovarian follicles in cattle. Reproduction 2007; 133: 617-26.
22. Sears R, Nuckolls F, Haura E, et al. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 2000; 14: 2501-14.
23. Ussar S, Voss T. MEK1 and MEK2, different regulators of the G1/S transition. J Biol Chem 2004; 279: 43861-9.
24. Berns K, Hijmans EM, Bernards R. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene 1997; 15: 1347-56.
25. Oster SK, Ho CS, Soucie EL, Penn LZ. The myc oncogene: MarvelouslY Complex. Adv Cancer Res 2002; 84: 81-154.
26. Johnston LA, Prober DA, Edgar BA, Eisenman RN, Gallant P. Drosophila myc regulates cellular growth during development. Cell 1999; 98: 779-90.
27. Kohno M, Pouyssegur J. Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. Prog Cell Cycle Res 2003; 5: 219-24.
28. Glaser SS, Gaudio E, Miller T, Alvaro D, Alpini G. Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med 2009; 11: e7.
29. Alpini G, Ulrich CD 2nd, Phillips JO, et al. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am J Physiol 1994; 266(5 Pt 1): G922-8.
30. Lesage G, Glaser SS, Gubba S, et al. Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion. Gastroenterology 1996; 111: 1633-44.
31. Lesage G, Glaser S, Alpini G. Regulation of cholangiocyte proliferation. Liver 2001; 21: 73-80.
32. Lesage G, Glaser S, Ueno Y, et al. Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. Am J Physiol Gastrointest Liver Physiol 2001; 281: G182-90.
33. Ravine D, Gibson RN, Walker RG, et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994; 343: 824-7.
34. Carpino G, Cardinale V, Onori P, et al. Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. J Anat 2012; 220: 186-99.
35. Kato A, Gores GJ, Larusso NF. Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism. J Biol Chem 1992; 267: 15523-9.
36. Lenzen R, Alpini G, Tavoloni N. Secretin stimulates bile ductular secretory activity through the cAMP system. Am J Physiol 1992; 263(4 Pt 1): G527-32.
37. Francis H, Glaser S, Ueno Y, et al. cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. J Hepatol 2004; 41: 528-37.
38. Lesage GD, Benedetti A, Glaser S, et al. Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver. Hepatology 1999; 29: 307-19.
39. Alpini G, Ulrich C, Roberts S, et al. Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol 1997; 272(2 Pt 1): G289-97.
40. Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272: 1339-42.
41. Hanaoka K, Qian F, Boletta A, et al. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000; 408: 990-4.
42. Nauli SM, Alenghat FJ, Luo Y, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 2003; 33: 129-37.
43. Van Keimpema L, De Koning DB, Van Hoek B, et al. Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases. Liver Int 2011; 31: 92-8.
44. Alvaro D, Alpini G, Onori P, et al. Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. Gastroenterology 2002; 123: 336-44.
45. Alvaro D, Metalli VD, Alpini G, et al. The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. J Hepatol 2005; 43: 875-83.
46. Alvaro D, Alpini G, Onori P, et al. Alfa and beta estrogen receptors and the biliary tree. Mol Cell Endocrinol 2002; 193: 105-8.
47. Park YH, Kim SJ, Jeong BH, et al. Follicular stimulating hormone enhances Notch 1 expression in SK-OV-3 ovarian cancer cells. J Gynecol Oncol 2010; 21: 119-24.
48. Liu HY, Zeng WD, Cao AL, Zhang CQ. Follicle-stimulating hormone promotes proliferation of cultured chicken ovarian germ cells through protein kinases A and C activation. J Zhejiang Univ Sci B 2010; 11: 952-7.
49. Dias JA, Cohen BD, Lindau-Shepard B, et al. Molecular, structural, and cellular biology of follitropin and follitropin receptor. Vitam Horm 2002; 64: 249-322.
50. Ulloa-Aguirre A, Zarinan T, Pasapera AM, Casas-Gonzalez P, Dias JA. Multiple facets of follicle-stimulating hormone receptor function. Endocrine 2007; 32: 251-63.
51. Chen H, Guo JH, Lu YC, et al. Impaired CFTR-dependent amplification of FSH-stimulated estrogen production in cystic fibrosis and PCOS. J Clin Endocrinol Metab 2012; 97: 923-32.
52. Stocco C. Aromatase expression in the ovary: hormonal and molecular regulation. Steroids 2008; 73: 473-87.
53. Francis H, Lesage G, Demorrow S, et al. The alpha2-adrenergic receptor agonist UK 14, 304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated rats. Am J Physiol Cell Physiol 2007; 293: C1252-62.
54. Alpini G, Franchitto A, Demorrow S, et al. Activation of alpha(1) -adrenergic receptors stimulate the growth of small mouse cholangiocytes via calcium-dependent activation of nuclear factor of activated T cells 2 and specificity protein 1. Hepatology 2011; 53: 628-39.
55. Francis H, Glaser S, Demorrow S, et al. Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. Am J Physiol Cell Physiol 2008; 295: C499-513.
56. Onori P, Wise C, Gaudio E, et al. Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor. Int J Cancer 2010; 127: 43-54.
57. Pasapera AM, Jimenez-Aguilera Mdel P, Chauchereau A, et al. Effects of FSH and 17beta-estradiol on the transactivation of estrogen-regulated promoters and cell proliferation in L cells. J Steroid Biochem Mol Biol 2005; 94: 289-302.
58. Gaudio E, Barbaro B, Alvaro D, et al. Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats. Am J Physiol Gastrointest Liver Physiol 2006; 291: G307-17.
59. Gaudio E, Barbaro B, Alvaro D, et al. Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology 2006; 130: 1270-82.
60. Kayampilly PP, Menon KM. Follicle-stimulating hormone increases tuberin phosphorylation and mammalian target of rapamycin signaling through an extracellular signal-regulated kinase-dependent pathway in rat granulosa cells. Endocrinology 2007; 148: 3950-7.
61. Harris TE, Lawrence JC Jr. TOR signaling. Sci STKE 2003; 212: re15.
62. Crespo JL, Hall MN. Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae. Microbiol Mol Biol Rev 2002; 66: 579-91, table of contents.
63. Oldham S, Hafen E. Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control. Trends Cell Biol 2003; 13: 79-85.
64. Renken C, Fischer DC, Kundt G, Gretz N, Haffner D. Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats. Nephrol Dial Transplant 2011; 26: 92-100.
65. Spee B, Carpino G, Schotanus BA, et al. Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling. Gut 2010; 59: 247-57.
66. Gaudio E, Carpino G, Cardinale V, et al. New insights into liver stem cells. Dig Liver Dis 2009; 41: 455-62.
67. Raynaud P, Tate J, Callens C, et al. A classification of ductal plate malformations based on distinct pathogenic mechanisms of biliary dysmorphogenesis. Hepatology 2011; 53: 1959-66.
68. Turner R, Lozoya O, Wang Y, et al. Human hepatic stem cell and maturational liver lineage biology. Hepatology 2011; 53: 1035-45.
69. Kida T, Nakanuma Y, Terada T. Cystic dilatation of peribiliary glands in livers with adult polycystic disease and livers with solitary nonparasitic cysts: an autopsy study. Hepatology 1992; 16: 334-40.
70. Ramos A, Torres VE, Holley KE, et al. The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. Arch Pathol Lab Med 1990; 114: 180-4.
71. Qian Q, Li A, King BF, et al. Clinical profile of autosomal dominant polycystic liver disease. Hepatology 2003; 37: 164-71.
72. Cardinale V, Wang Y, Carpino G, et al. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology 2011; 54: 2159-72.
73. Cardinale V, Wang Y, Carpino G, et al. The biliary tree - a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol 2012; 9: 231-40.
74. Semeraro R, Carpino G, Cardinale V, et al. Multipotent stem/progenitor cells in the human foetal biliary tree. J Hepatol 2012; 57: 987-94.